Zegocractin
Zegocractin (development code CM-4620) is a drug which acts as a selective inhibitor of the calcium channel ORAI1.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Zegocractin (development code CM-4620) is a drug which acts as a selective inhibitor of the calcium channel ORAI1. It inhibits store-operated calcium entry (SOCE) and has anti-inflammatory effects. It is being researched for the treatment of pancreatitis , including acute pancreatitis associated with systemic inflammatory response syndrome (completed phase 2b CARPO trial ).
Text derived from https://en.wikipedia.org/w/index.php?oldid=1373868673 under CC BY-SA 4.0; modifications have been made.